PCVX
Vaxcyte Inc
NASDAQ: PCVX · HEALTHCARE · BIOTECHNOLOGY
$57.32
-2.40% today
Updated 2026-04-29
Market cap
$8.28B
P/E ratio
—
P/S ratio
—
EPS (TTM)
$-5.63
Dividend yield
—
52W range
$28 – $65
Volume
1.3M
Vaxcyte Inc (PCVX) Financial statements
SEC filings — annual and quarterly data.
Cash flow — annual
| Item | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|
| Operating cash flow | $-14963.00 | $-30.47M | $-47.15M | $-46.63M | $-121.39M | $-170.60M | $-296.79M | $-452.63M | $-655.58M |
| Capital expenditures | $1222.00 | $1.77M | $1.20M | $1.16M | $6.55M | $5.84M | $67.88M | $22.43M | $13.71M |
| Depreciation | — | — | — | — | — | — | — | — | — |
| Stock-based comp | $390.00 | $749000.00 | $1.19M | $5.43M | $10.73M | $23.65M | $48.76M | $84.82M | $138.84M |
| Free cash flow | $-16185.00 | $-32.24M | $-48.34M | $-47.78M | $-127.95M | $-176.44M | $-364.67M | $-475.05M | $-669.29M |
| Investing cash flow | — | — | — | — | — | — | — | — | — |
| Financing cash flow | — | — | — | — | — | — | — | — | — |
| Dividends paid | — | — | — | $374000.00 | — | — | — | — | — |
| Share repurchases | — | — | — | — | — | — | — | — | — |
| Debt repayment | — | — | — | — | — | — | — | — | — |
| Net change in cash | — | — | — | $327.14M | $-315.90M | — | — | — | — |